tel: 86-731-84372980
Inspection Department
The CITIC Xiangya Reproductive and Genetic Specialty Hospital Medical Laboratory Department (hereinafter referred to as the Laboratory Department) is a comprehensive medical laboratory integrating medical treatment, teaching, and research. It covers an area of over 2000 square meters and has several sub-specialty groups, including clinical examination, clinical biochemistry, clinical immunology, clinical microbiology, and molecular diagnostics. The department has a high-quality and well-structured clinical laboratory diagnostic team with 26 staff members, including 9 senior professionals, 16 intermediate professionals, and 1 junior professional. Two hold doctoral degrees, five hold master's degrees, sixteen hold bachelor's degrees, and two hold other degrees. In addition, there is 1 doctoral supervisor, 1 master's supervisor, and 12 clinical laboratory physicians. The personnel quality, team building, and academic level are all reasonable, making it a strong team with rich clinical laboratory experience.
The department is built according to the national Class II biosafety laboratory standards, with complete biosafety supporting facilities. The pathogen microbiology laboratory, HIV antibody initial screening laboratory, and clinical gene amplification laboratory of the laboratory department have passed the acceptance inspection of the Changsha Municipal Health Commission's Class II biosafety laboratory.
The department currently has internationally renowned advanced testing equipment, including Roche CCM流水线系统, Abbott a3600流水线系统, Werfen blood coagulation流水线系统, Sorin chemiluminescence analyzer, Mindray BC-6800 blood cell analyzer, Italian Test-1 fully automatic erythrocyte sedimentation rate analyzer, Tecan fully automatic enzyme immunoassay analyzer, and bioMerieux microbial identification and drug sensitivity analyzer. It conducts over 100 routine and specialized tests, including clinical examination, biochemistry, immunology, microbiology, molecular diagnostics, sex hormones, eugenics, and immunologic infertility. Test reports are connected through the Laboratory Information System (LIS) and the hospital's computerized network information system (HIS), providing patients with timely, accurate, and effective 24-hour testing and diagnostic services.
The department establishes and strictly implements a quality management system in accordance with the ISO15189 standard, combined with the actual situation of the laboratory. It conducts daily internal quality control and participates in annual inter-laboratory quality assessments by the National Health Commission Clinical Testing Center, Hunan Provincial Clinical Testing Center, and the third-party quality control platform, Bio-Rad, obtaining qualification certificates and ensuring the accuracy of the test results.
The department passed the CNAS (China National Accreditation Service for Conformity Assessment) accreditation in December 2023.
The department attaches importance to the combination of clinical practice and research. It has published more than 30 SCI and CSCD indexed papers as the first or corresponding author. It has undertaken 1 National Natural Science Foundation of China project, 1 Hunan Provincial Natural Science Foundation key project, 1 Ministry of Education doctoral program new teacher fund project, 4 horizontal projects, and 2 internal projects. Twelve utility model patents have been granted, and three national invention patents have entered the substantive examination stage. Ten master's degree students have been trained.
Blood Bank Introduction
The blood bank is currently affiliated with the laboratory department, covering an area of 43 square meters. It is built according to the "Hunan Province Medical Institution Blood Transfusion Department (Blood Bank) Construction Standards" and has established a complete set of quality system documents that are strictly implemented. There are currently three staff members (part-time from the laboratory department) who can perform ABO blood typing, RH blood typing, cross-matching, and irregular antibody screening, basically meeting clinical needs.